Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage 3 Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00450138
What this trial is testing

Open Label, Phase I ZD6474 Head and Neck Cancer Study

Who this might be right for
Head and Neck Cancer
Sanofi 48
Testing effectiveness (Phase 2)Study completedNCT02339558
What this trial is testing

Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Nonkeratinizing CarcinomaRecurrent Nasopharynx CarcinomaStage III Nasopharyngeal Carcinoma AJCC v7+4 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT00055952
What this trial is testing

Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor

Who this might be right for
Sarcoma
Daiichi Sankyo
Testing effectiveness (Phase 2)UnknownNCT05113355
What this trial is testing

Chidamide Plus Sintilimab for Chemotherapy-refractory Advanced High-grade Neuroendocrine Neoplasm

Who this might be right for
Neuroendocrine TumorsNeuroendocrine Tumor Grade 3Neuroendocrine Carcinoma+1 more
Peking Union Medical College Hospital 23
Testing effectiveness (Phase 2)WithdrawnNCT05757843
What this trial is testing

Using Circulating Tumor DNA to Personalize Duration of Consolidation Durvalumab

Who this might be right for
NSCLC, Stage III
Indiana University
Large-scale testing (Phase 3)Looking for participantsNCT07164443
What this trial is testing

Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostatic Neoplasms
Janssen Research & Development, LLC 1,203
Testing effectiveness (Phase 2)Study completedNCT00003035
What this trial is testing

Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
Georgetown University 40
Testing effectiveness (Phase 2)Study completedNCT03781934
What this trial is testing

Evaluate MIV-818 in Patients With Liver Cancer Manifestations

Who this might be right for
Hepatocellular CarcinomaIntrahepatic CholangiocarcinomaLiver Metastases
Medivir 53
Testing effectiveness (Phase 2)UnknownNCT04462809
What this trial is testing

Efficacy of a Maintenance Treatment With TALAzoparib Following First Line Platinum-based Chemotherapy in Malignant MESOthelioma

Who this might be right for
Advanced Malignant Pleural or Peritoneal Mesothelioma
Hospices Civils de Lyon 40
Testing effectiveness (Phase 2)Ended earlyNCT00323063
What this trial is testing

Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Rutgers, The State University of New Jersey 49
Testing effectiveness (Phase 2)Looking for participantsNCT05327686
What this trial is testing

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Who this might be right for
Metastatic Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8+1 more
NRG Oncology 240
Testing effectiveness (Phase 2)Study completedNCT00052351
What this trial is testing

Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT05232851
What this trial is testing

A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer

Who this might be right for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Human Papillomavirus-Related CarcinomaLocally Advanced Oropharyngeal Carcinoma+2 more
Mayo Clinic 20
Not applicableUnknownNCT03025139
What this trial is testing

Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness)

Who this might be right for
Cancer SurvivorEarly-Stage Breast CarcinomaStage 0 Breast Cancer+7 more
Jonsson Comprehensive Cancer Center 96
Early research (Phase 1)Ended earlyNCT04021277
What this trial is testing

PS101-mediated ACT With Chemotherapy in Liver Metastases From Cancer of Gastrointestinal Origin

Who this might be right for
Solid TumorColorectal Cancer
EXACT Therapeutics AS 11
Not applicableStudy completedNCT00540241
What this trial is testing

Performance Status During Treatment With Pemetrexed in Patients With NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 542
Large-scale testing (Phase 3)Study completedNCT02893254
What this trial is testing

Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis

Who this might be right for
AS
Innovent Biologics (Suzhou) Co. Ltd. 438
Testing effectiveness (Phase 2)Study completedNCT00003222
What this trial is testing

Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
University of Virginia 40
Large-scale testing (Phase 3)UnknownNCT04667351
What this trial is testing

HAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority Trial

Who this might be right for
HepatoCellular Carcinoma
Sun Yat-sen University 400
Not applicableEnded earlyNCT04577729
What this trial is testing

The IRMI-FMT Trial

Who this might be right for
Fecal Microbiota TransplantationMalignant Melanoma Stage IIIMalignant Melanoma Stage IV
Medical University of Graz 5
Next Page